Safety and feasibility of NeuroFlo use in eight- to 24-hour ischemic stroke patients

International Journal of Stroke

Volumn 7, Issue 8, 2012, Pages 655-661

  Hammer, M D ^a   Schwamm, L ^b   Starkman, S ^c   Schellinger, P D ^d   Jovin, T ^d   Nogueira, R ^b   Burgin, W S ^e   Sen, S ^f   Diener, H C ^g   Watson, T ^h   Michel, P ⁱ   Shuaib, A ^j   Dillon, W ^k   Liebeskind, D S ^c  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^e UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^f UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY HOSPITAL ESSEN   (Germany)

^h UNIVERSITY OF CALGARY   (Canada)

ⁱ LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^j UNIVERSITY OF ALBERTA   (Canada)

^k UNIVERSITY OF CALIFORNIA   (United States)

more..

Author keywords

Acute stroke therapy; Cerebral blood flow; Cerebral infarction; Clinical trial; Intervention; Stroke

Indexed keywords

ANTIBIOTIC AGENT;

ABSCESS; ADULT; ADVERSE OUTCOME; AGED; ANEMIA; AORTA OCCLUSION; ARTICLE; BALLOON CATHETER; BRAIN EDEMA; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CATHETER COMPLICATION; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONFUSION; DEEP VEIN THROMBOSIS; DELIRIUM; DEVICE SAFETY; DISEASE SEVERITY; FALSE ANEURYSM; FEASIBILITY STUDY; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEMATOMA; HUMAN; INFECTIOUS PNEUMONIA; INTERNAL CAROTID ARTERY OCCLUSION; MALE; MULTICENTER STUDY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PARENCHYMA; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; RANKIN SCALE; RESPIRATORY FAILURE; SEIZURE; SEPSIS; THIGH; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AORTA, ABDOMINAL; BALLOON OCCLUSION; BLOOD FLOW VELOCITY; CEREBRAL INFARCTION; CEREBROVASCULAR CIRCULATION; FEASIBILITY STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; STROKE; TIME-TO-TREATMENT; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84869046582     PISSN: 17474930     EISSN: 17474949     Source Type: Journal    
DOI: 10.1111/j.1747-4949.2011.00719.x     Document Type: Article

References (17)

1. The National Institute of Neurologic Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995; 333:1581-1587.
2. Hacke W, Kaste M, Bluhmki E etal., for the ECASS Investigators. Thrombolysis with alteplase 3 to 4.5hours after acute ischemic stroke. N Engl J Med 2008; 359:1317-1329.
3. Nogueira RG, Yoo AJ, Buonanno FS, Hirsch JA. Endovascular approaches to acute stroke, part 2: a comprehensive review of studies and trials. AJNR Am J Neuroradiol 2009; 30:859-875.
4. Furlan A. IV Tissue Plasminogen Activator for stroke in the community. What we know and don't know 10 years after FDA approval. Stroke 2006; 37:281.
5. Liebeskind D. Collateral therapeutics for cerebral ischemia. Expert Rev Neurother 2004; 4:255-265.
6. Liebeskind D. Collaterals in acute stroke: beyond the clot. Neuroimaging Clin N Am 2005; 15:553-573.
7. Liebeskind D. Aortic occlusion for cerebral ischemia: from theory to practice. Curr Cardiol Rep 2008; 10:31-36.
8. Stokland O, Miller MM, Ilebekk A, Kiil F. Mechanism of hemodynamic responses to occlusion of the descending thoracic aorta. Am J Physiol 1980; 238:H423-429.
9. Saether OD, Juul R, Aadahl P, Strømholm T, Myhre HO. Cerebral haemodynamics during thoracic and throacoabdominal aortic aneurysm repair. Eur J Vasc Endovasc Surg 1996; 12:81-85.
10. Noor R, Wang CX, Todd K, Elliott C, Wahr J, Shuaib A. Partial intra-aortic occlusion improves perfusion deficits and infarct size following focal cerebral ischemia. J Neuroimaging 2009; 20:1-5 (accepted for publication, available online).
11. Simeone FA. Enhancement of cerebral blood flow by intermittent aortic occlusion. Eur Neurol 1972; 8:142-144.
12. Hammer M, Jovin T, Wahr JA, Heiss W-D. Partial occlusion of the descending aorta increases cerebral blood flow in a nonstroke porcine model. Cerebrovasc Dis 2009; 28:406-410.
13. Lylyk P, Vila JF, Miranda C, Ferrario A, Romero R, Cohen J. Partial aortic obstruction improves cerebral perfusion and clinical symptoms in patients with symptomatic vasospasm. Neurol Res 2005; 27:S129-135.
14. Saver JL, Albers GW, Dunn B, Johnson KC, Fisher M, for the STAIR VI Consortium. Stroke Therapy Academic Industry Roundtable (STAIR) recommendations for extended window acute stroke therapy trials. Stroke 2009; 40:2594-2600.
15. Furlan A, Higashida R, Wechsler L etal., for the PROACT Investigators. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. JAMA 1999; 282:2003-2011.
16. Berger C, Fiorelli M, Steiner T etal. Hemorrhagic transformation of ischemic brain tissue: asymptomatic or symptomatic? Stroke 2001; 32:1330-1335.
17. Albers GW, Thijs VN, Wechsler L etal., for the DEFUSE Investigators. Magnetic resonance imaging profiles predict clinical response to early reperfusion: the Diffusion and Perfusion Imaging Evaluation for Understanding Stroke Evolution (DEFUSE) Study. Ann Neurol 2006; 60:508-517.